FDA-Drug2025-04-16Class II
Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.
Glenmark Pharmaceuticals Inc., USA
Hazard
CGMP Deviations
Sold states
U.S. Nationwide
Affected count
N/A
Manufactured in
750 Corporate Dr, N/A, Mahwah, NJ, United States
Products
Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0351-2025Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief